• The New Money
  • Posts
  • A Deal For The Golden Dome, Going All In On Psychedelic Medicines In America, And Saudi Arabia's Mega Deal For Rare Earth Processing

A Deal For The Golden Dome, Going All In On Psychedelic Medicines In America, And Saudi Arabia's Mega Deal For Rare Earth Processing

The markets and trends that matter, made simple. Discover what’s next.

January 17, 2026

AST SpaceMobile Wins New Deal For The Golden Dome

AST SpaceMobile (NASDAQ: ASTS) won a new contract for the Missile Defense Agency SHIELD program to become a prime contractor. The Missile Defense Agency’s SHIELD program is part of their broader strategy for the Golden Dome which is has quickly come into focus as a critical national initiative to protect the United States from possible advanced missile threats.

Christian Angermayer’s AtaiBeckley Is All In On Psychedelic Medicines In America

Psychedelic drug development company AtaiBeckley (NASDAQ: ATAI) officially completed their redomiciliation into the United States of America, bringing one of the largest clinical pipeline of psychedelic derived medicines of any publicly listed company to the U.S. AtaiBeckley is co-founded by prominent billionaire investor Christian Angermayer and has multiple notable backers including Peter Thiel, Mike Novogratz and Switzerland based pharmaceutical giant Ferring.

Critical Metals Lands Mega Deal For A Rare Earth Processing Plant In Saudi Arabia

Critical Metals (NASDAQ: CRML) entered into a new joint venture with Saudi Arabian industrial giant Tariq Abdel Hadi Abdullah Al-Qahtani & Brothers Company to build a new rare earth processing facility in Saudi Arabia. The new joint venture will commit up to $1.5 billion in total investment, and Critical Metals will commit 25% of the offtake rights from their flagship rare earth project Tanbreez located in Greenland.

The Eric Brock Interview: Drones And The Race For American Defense Dominance

The New Money App is here. Discover the world’s most exciting stocks. Breaking news, exclusive interviews and more.

The Sprint

The Markets This Week

+84.4% | Tygo Energy

+60.9% | Alt5 Sigma

+43.7% | BioAge Labs

+32.2% | Super Copper

Top Trends This Week

+11.8% | Mike Alfred

Looking to connect? Reach out and get in touch.

New here? Join our community of 100,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.